Get my own profile
Public access
View all26 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Marc PilonUniversity of GothenburgVerified email at cmb.gu.se
- Jan BorénUniversity of GothenburgVerified email at wlab.gu.se
- Ranjan DevkotaUniversity of Gothenburg, Sri Sathya Sai Institute of Higher LearningVerified email at gu.se
- Colin CorrentiVerified email at linkimmunotherapeutics.com
- Maria D. GanforninaIBGM, Universidad de Valladolid-CSICVerified email at ibgm.uva.es
- Diego SanchezIBGM, Universidad de Valladolid-CSICVerified email at ibgm.uva.es
- Roland StrongFred Hutchinson Cancer Research CenterVerified email at fhcrc.org
- Bjorn DahlbackLund UniversityVerified email at med.lu.se
- Rakesh BodhicharlaVerified email at gu.se
- Henrik PalmgrenIndustrial PhD student at AstraZeneca BioPharmaceuticalsVerified email at astrazeneca.com
- kiran BusayavalasaUniversity of GothenburgVerified email at gu.se
- Mohammad Bohlooly-YExecutive Director AstraZenecaVerified email at astrazeneca.com
- Emma SvenskSveriges 3R-center, JordbruksverketVerified email at jordbruksverket.se
- Matthew CliftonHead, Structural and Biophysical Chemistry, NovartisVerified email at novartis.com
- Xiao-Rong PengAstraZeneca RDVerified email at astrazeneca.com
- Ángel Acebes VindelInstituto de Tecnologías Biomédicas, Facultad de Medicina, Universidad de La LagunaVerified email at ull.es
- Delaney KaperUniversity of GothenburgVerified email at gu.se
- Dimitra PanagakiPhD, Molecular BiologistVerified email at gu.se
- Nils-Olov HermanssonAstraZenecaVerified email at ekompetens.se
- Marcus HenricssonPrinciple Research Engineer, Gothenburg University, SwedenVerified email at wlab.gu.se